Tyrosine kinase inhibitors and gut toxicity: a new era in supportive care.
Keefe
Dorothy
D
Royal Adelaide Hospital, North Terrace, Adelaide, South Australia, Australia. dorothy.keefe@health.sa.gov.au
Anthony
Lowell
L
D005767:Gastrointestinal Diseases / Q000139:chemically induced*; D041981:Gastrointestinal Tract / Q000187:drug effects*; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy*; D010879:Piperazines / Q000008:administration & dosage / Q000009:adverse effects; D047428:Protein Kinase Inhibitors / Q000008:administration & dosage / Q000009:adverse effects*; D011505:Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors; D011743:Pyrimidines / Q000008:administration & dosage / Q000009:adverse effects
D010879:Piperazines; D047428:Protein Kinase Inhibitors; D011743:Pyrimidines; D011505:Protein-Tyrosine Kinases